Stipple Bio
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $75M
Investors
- 8
About Stipple Bio
Stipple Bio, Inc.Founded in 2022 and headquartered in Cambridge, US, Stipple Bio, Inc. specializes in the research and development of targeted cancer therapies.Stipple Bio is focused on revolutionizing targeted oncology through the development of precision medicines aimed at treating cancer. Their core offerings center around the identification and mapping of tumor-specific epitopes, utilizing a unique approach that emphasizes the detection of subtle molecular points—termed "dots"—to create a comprehensive therapeutic picture. This methodology allows Stipple Bio to systematically differentiate between established, emerging, and novel tumor targets that conventional antibody discovery methods often overlook. The end users of these products include healthcare providers and research institutions, primarily in North America and Europe, who are seeking advanced options for targeted cancer therapies.Stipple Bio’s revenue model is primarily structured around partnerships with healthcare providers, research institutions, and potentially pharmaceutical companies, enabling the commercialization of their innovative cancer therapies. Transactions are carried out through collaborations and licensing agreements, allowing clients to integrate Stipple Bio's proprietary technologies into their own research and treatment protocols. Typical transaction structures may involve collaborative research agreements, where Stipple Bio partners with biotech firms or academic institutions to develop targeted therapies, as well as direct sales of their proprietary technologies.In March 2026, Stipple Bio, Inc. Stipple Bio is focused on launching new products and expanding its market reach, particularly in North America and Europe, to enhance its offerings in targeted oncology.
Who invested in Stipple Bio
8 investors across 2 rounds
See all investors in Stipple Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stipple Bio
Who invested in Stipple Bio?
Stipple Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stipple Bio raised?
Stipple Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Stipple Bio last raise money?
Stipple Bio's most recent round on record is a Series A, in Mar 2026.
What does Stipple Bio do?
Stipple Bio is a biotechnology company.
Where is Stipple Bio headquartered?
Stipple Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Stipple Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Stipple Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Stipple Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.